Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
75.17
-4.97 (-6.20%)
At close: Oct 10, 2025, 4:00 PM EDT
76.00
+0.83 (1.10%)
After-hours: Oct 10, 2025, 7:57 PM EDT
Inspire Medical Systems Market Cap
Inspire Medical Systems has a market cap or net worth of $2.22 billion as of October 10, 2025. Its market cap has decreased by -64.23% in one year.
Market Cap
2.22B
Enterprise Value
1.96B
1-Year Change
-64.23%
Ranking
Category
Stock Price
$75.17
Market Cap Chart
Since May 3, 2018, Inspire Medical Systems's market cap has increased from $505.61M to $2.22B, an increase of 339.68%. That is a compound annual growth rate of 22.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 2.22B | -59.98% |
| Dec 31, 2024 | 5.56B | -7.51% |
| Dec 29, 2023 | 6.01B | -17.47% |
| Dec 30, 2022 | 7.28B | 15.62% |
| Dec 31, 2021 | 6.29B | 24.23% |
| Dec 31, 2020 | 5.07B | 191.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |